AI Terminal
DIRECTA PLUS PLC
Board/Management Information • Nov 10, 2023
7601_rns_2023-11-10_e9813edc-8fdb-45bc-b9c7-75bdee3314bf.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9971S
Directa Plus PLC
10 November 2023
10 November 2023
Directa Plus plc
("Directa Plus" or the "Company" or, together with its subsidiaries, the "Group")
Change of Nominated Adviser
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, announces that, following the completion of the all-share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), and as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.
For further information please visit or contact:
| Directa Plus plc | +39 02 36714458 |
| Giulio Cesareo, CEO | |
| Giorgio Bonfanti, CFO | |
| Cavendish Capital Markets (Nominated Adviser and Joint Broker) | +44 131 220 6939 |
| Neil McDonald | |
| Adam Rae | |
| Singer Capital Markets Securities Limited (Joint Broker) | +44 20 7496 3069 |
| Rick Thompson | |
| Phil Davies | |
| Alma (Financial PR Adviser) | +44 20 3405 0205 |
| Justine James | [email protected] |
| Hannah Campbell | |
| Kinvara Verdon |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPFSWFMUEDSEDF